| Name | (S)-N-BOC-Azetidine carboxylic acid |
| Synonyms | Boc-Aze-OH 1-Boc-L-azetidine-2-carboxylic acid (S)-N-BOC-Azetidine carboxylic acid (S)-1-Boc-2-azetidinecarboxylic acid (S)-N-BOC-Azetidine-2-carboxylic acid (S)-1-BOC-AZETIDINE-2-CARBOXYLIC ACID BOC-L-AZETIDINE-2CARBOXYLIC ACID BOC-L-AZE-OH (2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylate (S)-N-tert-Butoxycarbonyl-azetidine-2-carboxylic acid (S)-Azetidine-1,2-dicarboxylic acid 1-tert-butyl ester N-ALPHA-T-BUTOXYCARBONYL-L-AZETIDINE-2-CARBOXYLIC ACID (2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid |
| CAS | 51077-14-6 |
| InChI | InChI=1/C9H15NO4/c1-9(2,3)14-8(13)10-5-4-6(10)7(11)12/h6H,4-5H2,1-3H3,(H,11,12)/p-1/t6-/m0/s1 |
| InChIKey | JWJVSDZKYYXDDN-LURJTMIESA-N |
| Molecular Formula | C9H15NO4 |
| Molar Mass | 201.22 |
| Density | 1.2250 (rough estimate) |
| Melting Point | 105-110 °C |
| Boling Point | 339.14°C (rough estimate) |
| Flash Point | 147.935°C |
| Solubility | Dichloromethane, DMSO, Ethyl Acetate, Methanol |
| Vapor Presure | 0mmHg at 25°C |
| Appearance | Solid |
| Color | White |
| pKa | 4.01±0.20(Predicted) |
| Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
| Refractive Index | 1.4640 (estimate) |
| MDL | MFCD01321011 |
| Hazard Symbols | Xi - Irritant![]() |
| Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
| WGK Germany | 3 |
| HS Code | 29339900 |
| Hazard Class | IRRITANT |
| Overview | The parent core structure of 1-Boc-L-acridin-2-carboxylic acid S-azetin-2-carboxylic acid is an important Pharmaceutical intermediates exist in many natural products. As a pharmaceutical intermediate, it can be used to synthesize thrombin inhibitor Melagatran or Exenta, and as a lower homolog of proline in polypeptide chemistry. |
| Uses | 1-Boc-L-acridin-2-carboxylic acid is a carboxylic acid organic compound and can be used as a pharmaceutical intermediate. |